tirzepatide surmount-1 trial weight loss non-diabetic SURMOUNT‐1 study design. This is a phase 3, multicenter, randomized surmount-1 trial tirzepatide non-diabetic obesity
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
















:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)










